Cardinal Health (NYSE:CAH) Price Target Raised to $270.00

Cardinal Health (NYSE:CAH) had its price objective hoisted by Jefferies Financial Group from $220.00 to $270.00 in a report issued on Thursday morning,MarketScreener reports. They currently have a buy rating on the stock.

CAH has been the subject of several other research reports. Citigroup raised Cardinal Health from a “neutral” rating to a “buy” rating and raised their target price for the stock from $190.00 to $244.00 in a research note on Friday, January 9th. Leerink Partners set a $240.00 price target on Cardinal Health in a report on Tuesday, January 13th. UBS Group boosted their price objective on shares of Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a report on Friday, October 31st. Evercore ISI upped their target price on shares of Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a research report on Friday, October 31st. Finally, Weiss Ratings reiterated a “buy (b)” rating on shares of Cardinal Health in a research report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $221.07.

Cardinal Health Trading Up 0.7%

Shares of CAH opened at $208.29 on Thursday. Cardinal Health has a 12-month low of $120.72 and a 12-month high of $215.48. The firm has a market capitalization of $49.49 billion, a P/E ratio of 31.42, a P/E/G ratio of 1.41 and a beta of 0.65. The firm has a 50-day moving average price of $205.78 and a 200 day moving average price of $176.26.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, beating the consensus estimate of $2.22 by $0.33. The company had revenue of $64.01 billion for the quarter, compared to analyst estimates of $59.41 billion. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. Cardinal Health’s revenue was up 22.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.88 EPS. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Equities research analysts predict that Cardinal Health will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd were given a dividend of $0.5107 per share. This represents a $2.04 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend was Friday, January 2nd. Cardinal Health’s dividend payout ratio is currently 30.77%.

Institutional Investors Weigh In On Cardinal Health

Large investors have recently added to or reduced their stakes in the business. Aventura Private Wealth LLC acquired a new position in shares of Cardinal Health in the fourth quarter worth $25,000. SJS Investment Consulting Inc. grew its stake in Cardinal Health by 1,363.6% during the 3rd quarter. SJS Investment Consulting Inc. now owns 161 shares of the company’s stock worth $25,000 after purchasing an additional 150 shares in the last quarter. Atlantic Edge Private Wealth Management LLC increased its holdings in Cardinal Health by 75.0% during the 2nd quarter. Atlantic Edge Private Wealth Management LLC now owns 175 shares of the company’s stock worth $29,000 after purchasing an additional 75 shares during the period. Barnes Dennig Private Wealth Management LLC raised its position in Cardinal Health by 38.7% in the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after purchasing an additional 53 shares in the last quarter. Finally, JPL Wealth Management LLC purchased a new position in shares of Cardinal Health in the 3rd quarter valued at about $31,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.